The Kraft Group

Claim is a social shopping application designed to enhance brand discovery through an engaging and interactive user experience. The platform allows brands to invest directly in customer acquisition by offering weekly promotional events known as Drops, which cater primarily to Gen Z consumers. Users can earn cash-back, gain exclusive access to events, and receive free merchandise while shopping at their preferred brands. Additionally, Claim facilitates a unique social aspect by enabling customers to share benefits with friends through gifting and trading rewards, thereby creating a community-driven shopping experience.

Prolific Machines is a biotech company founded in 2020 and based in San Francisco, California. The company specializes in developing advanced cell technologies aimed at transforming the production of cells for sustainable applications, particularly in the cultivated meat industry. By leveraging high-scale precision cell-differentiation techniques, Prolific Machines focuses on research and development in clean meat, cell therapies, and sustainable solutions for multi-planetary existence. Its innovations enable partners to adopt more sustainable practices, thereby enhancing human and planetary health while improving efficiency, quality, reproducibility, and sustainability in cell production.

Stackwell Capital is a fintech firm focused on addressing the racial wealth gap in America by providing a digital investment platform tailored for the Black community. The company aims to enhance financial literacy and investment participation among Black Americans through its innovative platform, which incorporates principles of behavioral psychology to encourage increased investment activity. Stackwell's offerings include automated portfolio construction and in-app educational resources designed to overcome social and emotional barriers to investing. By fostering a supportive environment for financial growth, Stackwell seeks to build long-term wealth and promote equity and opportunity within the community. The firm is also involved in prominent accelerator programs, further underscoring its commitment to developing effective financial solutions.

CAMP4 Therapeutics Corporation is a bioinformatics company founded in 2015 and based in Cambridge, Massachusetts. The company specializes in gene regulation circuitry, focusing on the fundamental causes of diseases by manipulating gene expression. Utilizing its proprietary 4-D gene circuitry platform, CAMP4 codifies the activation of approximately 24,000 human genes into a discrete set of combinatorial rules based on existing cellular signaling pathways. This innovative approach allows CAMP4 to effectively control gene production, thereby accelerating the development of new therapies. By employing this technology, the company aims to streamline the drug development process, significantly reducing both the time and risks associated with bringing new medicines to patients.

Evolved By Nature, Inc. is a biotech company that specializes in the development and manufacturing of chemicals derived from silk protein, specifically through its patented Activated Silk technology. Founded in 2013 and based in Medford, Massachusetts, the company aims to create sustainable silk molecules that reduce reliance on harmful chemicals while enhancing the performance of existing materials. Evolved By Nature produces a variety of products for use in fabrics, personal care, and medical applications, focusing on skincare solutions that offer anti-aging benefits without synthetic fillers or harsh preservatives. The company's innovative approach utilizes pure silk in liquid form, created from discarded silkworm cocoons, showcasing a commitment to environmental sustainability and health.

Jackpot.com is modernizing the way Americans play the lottery. Jackpot.com brings verified, official state lottery tickets online by leveraging its digital platform to give customers the ability to play right from your phone, tablet, or desktop. Jackpot.com has invested significantly in responsible gaming safeguards, with default spending limits and other features built in throughout the experience, which earned them a certification from the National Council on Problem Gaming. To learn more, visit jackpot.com or download the iOS or Android app.

Relief is a mobile app that delivers on debt-elimination commitment. They aim to become the company that people come to for help getting back in the black. By developing products and services that are simple, effective, and easy to use, they will make financial relief accessible to those who need it.

Wagr operates as an online mobile application facilitating social sports betting in the United States. The company offers users a platform to engage in peer-to-peer wagering, challenge friends, create groups, and monitor leaderboards within a secure and regulated environment.

Evolved By Nature, Inc. is a biotech company that specializes in the development and manufacturing of chemicals derived from silk protein, specifically through its patented Activated Silk technology. Founded in 2013 and based in Medford, Massachusetts, the company aims to create sustainable silk molecules that reduce reliance on harmful chemicals while enhancing the performance of existing materials. Evolved By Nature produces a variety of products for use in fabrics, personal care, and medical applications, focusing on skincare solutions that offer anti-aging benefits without synthetic fillers or harsh preservatives. The company's innovative approach utilizes pure silk in liquid form, created from discarded silkworm cocoons, showcasing a commitment to environmental sustainability and health.

Mythical Games Inc. is a game technology studio founded in 2018 and based in Sherman Oaks, California, with an additional office in Seattle, Washington. The company develops blockchain-based games and aims to create a new generation of gaming experiences by enabling true ownership of digital assets, verifiable scarcity, and integrated secondary markets. Its flagship title, Blankos, is a casual multiplayer game where players can buy, trade, and sell their unique designs. Mythical Games also provides tools for content creators and brands, allowing them to customize and own game assets. By fostering a decentralized gaming ecosystem, the company brings players, developers, and content creators together, promoting personalized experiences and driving consumer adoption of distributed ledger technology through innovative gaming products.

CAMP4 Therapeutics Corporation is a bioinformatics company founded in 2015 and based in Cambridge, Massachusetts. The company specializes in gene regulation circuitry, focusing on the fundamental causes of diseases by manipulating gene expression. Utilizing its proprietary 4-D gene circuitry platform, CAMP4 codifies the activation of approximately 24,000 human genes into a discrete set of combinatorial rules based on existing cellular signaling pathways. This innovative approach allows CAMP4 to effectively control gene production, thereby accelerating the development of new therapies. By employing this technology, the company aims to streamline the drug development process, significantly reducing both the time and risks associated with bringing new medicines to patients.

Premier Lacrosse League is a professional lacrosse organization in North America that aims to elevate the sport through a tour-based model. It features a roster of top players, showcasing the biggest stars in lacrosse and providing fans with an engaging entertainment experience. By operating a series of tournaments, the league seeks to bring lacrosse to a national audience, promoting its growth and popularity. In addition to its events, Premier Lacrosse League also sells sports-related apparel online, further connecting with its fanbase and enhancing the overall lacrosse experience.

Rowdy Energy is a beverage company that specializes in the production of energy drinks designed to enhance focus and performance. Its products feature a unique blend of caffeine and the nootropic L-Theanine, which provides a sustained energy boost while minimizing the risk of an energy crash. The drinks also incorporate electrolytes to support hydration and overall physical performance. Rowdy Energy offers a variety of ten flavors, including seven sugar-free and KETO-certified options, catering to health-conscious consumers seeking reduced sugar content. Additionally, the company diversifies its offerings by producing clothing and accessories related to its brand.

ProMIS Neurosciences, Inc. is a development-stage biotechnology company based in Toronto, Canada, focused on developing precision therapeutic solutions for neurodegenerative diseases, primarily Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS), and Parkinson’s disease (PD). Established in 2004, the company employs a proprietary target discovery engine that integrates thermodynamic and computational techniques to identify disease-specific epitopes on misfolded proteins. Its lead product candidates include PMN310, PMN350, and PMN330, which are monoclonal antibodies targeting toxic forms of amyloid beta oligomers and prion-like proteins associated with AD. Additionally, ProMIS is developing treatments targeting the neurotoxic tau protein in AD and proteins linked to ALS and PD. The company collaborates with BC Neuroimmunology to advance proprietary diagnostic assays and blood-based tests for Alzheimer’s disease, enhancing early detection and treatment efficacy. Formerly known as Amorfix Life Sciences Ltd., ProMIS Neurosciences has rebranded itself to reflect its focus on neurological therapeutics.

River Financial Inc. is a financial technology company based in San Francisco, California, founded in 2019 by Alexander Leishman and Andrew Benson. The company specializes in providing a platform for individuals and institutions to buy, manage, and sell bitcoin. Its flagship product is a Bitcoin brokerage designed for sophisticated retail investors, offering a high-touch service that prioritizes security and client experience. River Financial's platform includes tools for investment performance, such as cost basis tracking, catering to the needs of its clients in the evolving cryptocurrency market.

Songclip™ is a new licensed music format built specifically for texting, social posts, and quick communication. Songclip’s multi-patented networked product solution, the Songclip API, integrates seamlessly into social platforms, mobile apps, and virtual marketplaces to drive expression, monetization, and music streaming. Songclip operates the world’s foremost searchable library of 5-30 second meta-tagged music clips, in partnership with the music industry. For more information, visit songclip.com

Delegate is a technology company based in San Francisco, California, with additional offices in Boston, Massachusetts, and Beersheba, Israel. It specializes in a software application designed to manage personal tasks and assignments efficiently. The company offers an innovative service known as "Chief of Stuff," which provides users with a comprehensive solution for handling various personal responsibilities. By combining advanced artificial intelligence with human expertise, Delegate ensures that tasks are completed with high quality and convenience. The aim is to make these services affordable, allowing individuals to focus on what truly matters to them while delegating other tasks to the company.

Butler Hospitality is an on-demand platform for room service and amenities. Butler Hospitality delivers amazing gourmet amenities right to any hotel room and specializes in providing offsite room service for limited-service hotels. Butler Hospitality was founded in 2017 in New York City.

Silk Therapeutics develops, manufactures, and sells skincare products based on silk materials. It offers PureProC, a film formulation that surrounds, protects, stabilizes, and delivers the benefits of vitamin C for an extended duration with anti-aging and skin health benefits. The company sells its products through its online store. Silk Therapeutics skincare line features clean, highly effective anti-aging skincare and skin health products that are healthy enough to use on any skin type, including highly sensitive skin. The company's proprietary liquid silk technology platform was developed by company co-founders Greg Altman, Ph.D., and Rebecca Horan, Ph.D., foremost experts in the use of silk for health and wellness solutions—including effective stabilization and delivery of real silk molecules to the skin. Silk Therapeutics, Inc. was incorporated in 2013 and is based in Medford, Massachusetts.

CAMP4 Therapeutics Corporation is a bioinformatics company founded in 2015 and based in Cambridge, Massachusetts. The company specializes in gene regulation circuitry, focusing on the fundamental causes of diseases by manipulating gene expression. Utilizing its proprietary 4-D gene circuitry platform, CAMP4 codifies the activation of approximately 24,000 human genes into a discrete set of combinatorial rules based on existing cellular signaling pathways. This innovative approach allows CAMP4 to effectively control gene production, thereby accelerating the development of new therapies. By employing this technology, the company aims to streamline the drug development process, significantly reducing both the time and risks associated with bringing new medicines to patients.

Scholar Rock, Inc. is a biotechnology company based in Cambridge, Massachusetts, specializing in the discovery and development of biologic therapies that selectively target dysregulated growth factors within disease microenvironments. The company's innovative approach focuses on modulating supracellular activation to address serious diseases, including fibrosis, musculoskeletal disorders, immuno-oncology, and autoimmune diseases. Scholar Rock's lead product candidate, SRK-015, is a first-in-class inhibitor designed to target the activation of the growth factor myostatin in skeletal muscle, specifically for the treatment of spinal muscular atrophy. The company is advancing this candidate through clinical development while also leveraging its proprietary platform to create a pipeline of additional product candidates aimed at transforming treatment for various serious conditions, including other neuromuscular disorders, cancer, and anemia.

Silk Therapeutics develops, manufactures, and sells skincare products based on silk materials. It offers PureProC, a film formulation that surrounds, protects, stabilizes, and delivers the benefits of vitamin C for an extended duration with anti-aging and skin health benefits. The company sells its products through its online store. Silk Therapeutics skincare line features clean, highly effective anti-aging skincare and skin health products that are healthy enough to use on any skin type, including highly sensitive skin. The company's proprietary liquid silk technology platform was developed by company co-founders Greg Altman, Ph.D., and Rebecca Horan, Ph.D., foremost experts in the use of silk for health and wellness solutions—including effective stabilization and delivery of real silk molecules to the skin. Silk Therapeutics, Inc. was incorporated in 2013 and is based in Medford, Massachusetts.

Dune Medical Devices, established in 2002, specializes in innovative tissue characterization technologies aimed at improving cancer detection and treatment. The company's flagship product, the MarginProbe™ System, utilizes a proprietary radiofrequency spectroscopy platform to provide real-time detection of cancerous tissue during surgical procedures. This system allows surgeons to assess the margins of excised tissue, addressing the critical concern of whether all cancerous cells have been removed. Clinical research has demonstrated that the use of the MarginProbe™ System significantly reduces reoperation rates for breast cancer patients, thereby enhancing the effectiveness of surgical interventions. By enabling more accurate differentiation between cancerous and healthy tissue, Dune Medical Devices aims to improve patient outcomes and streamline the cancer care experience.

Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, dedicated to developing innovative treatments for multi-drug resistant (MDR) bacterial infections and rare diseases. Founded in 2013, the company is advancing several product candidates, including tebipenem pivoxil hydrobromide, an oral carbapenem-class antibiotic aimed at treating MDR gram-negative infections in adults. Additionally, Spero is developing SPR206, an intravenous agent for MDR gram-negative infections in hospital settings, and SPR720, an oral antibiotic targeting pulmonary non-tuberculous mycobacterial disease. The company collaborates with various partners, including Meiji Seika Pharma to support tebipenem HBr's development and the Bill & Melinda Gates Medical Research Institute for SPR720. Spero Therapeutics employs a focused approach to drug development, emphasizing novel mechanisms to address the urgent need for effective therapeutics against serious bacterial infections.

Silk Therapeutics develops, manufactures, and sells skincare products based on silk materials. It offers PureProC, a film formulation that surrounds, protects, stabilizes, and delivers the benefits of vitamin C for an extended duration with anti-aging and skin health benefits. The company sells its products through its online store. Silk Therapeutics skincare line features clean, highly effective anti-aging skincare and skin health products that are healthy enough to use on any skin type, including highly sensitive skin. The company's proprietary liquid silk technology platform was developed by company co-founders Greg Altman, Ph.D., and Rebecca Horan, Ph.D., foremost experts in the use of silk for health and wellness solutions—including effective stabilization and delivery of real silk molecules to the skin. Silk Therapeutics, Inc. was incorporated in 2013 and is based in Medford, Massachusetts.

Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, dedicated to developing innovative treatments for multi-drug resistant (MDR) bacterial infections and rare diseases. Founded in 2013, the company is advancing several product candidates, including tebipenem pivoxil hydrobromide, an oral carbapenem-class antibiotic aimed at treating MDR gram-negative infections in adults. Additionally, Spero is developing SPR206, an intravenous agent for MDR gram-negative infections in hospital settings, and SPR720, an oral antibiotic targeting pulmonary non-tuberculous mycobacterial disease. The company collaborates with various partners, including Meiji Seika Pharma to support tebipenem HBr's development and the Bill & Melinda Gates Medical Research Institute for SPR720. Spero Therapeutics employs a focused approach to drug development, emphasizing novel mechanisms to address the urgent need for effective therapeutics against serious bacterial infections.

Skillz is a mobile games platform focused on enhancing competition through engaging gameplay. It enables game developers to create successful franchises by facilitating social competition within their games. Utilizing patented technology, Skillz hosts billions of casual gaming tournaments, attracting millions of players globally. As a leader in skill-based mobile gaming, the company offers a variety of games, including Dominoes Gold, Blackout Bingo, 21 Blitz, and Solitaire Cube. Skillz operates primarily through its eSports gaming platform, which allows developers to monetize their content via multiplayer competitions. The company generates most of its revenue from the United States, with additional income from international markets such as Israel, China, and Malta. Skillz has received recognition for its workplace culture and innovation in the technology sector.

DraftKings Inc. is a digital sports entertainment and gaming company based in Boston, Massachusetts. Founded in 2011, it initially focused on daily fantasy sports contests for cash prizes across major sports in the United States and Canada. Following the 2018 Supreme Court ruling that allowed states to legalize online sports wagering, DraftKings expanded its offerings to include online sports betting and casino gaming. Currently, the company operates in 27 states for online or retail sports betting and in seven states for iGaming, reaching approximately 40% of Canada's population. In addition to its core gaming services, DraftKings designs and develops software for sports betting and casino gaming platforms, and it also manages a marketplace for non-fungible tokens.

Delphix is a technology company that offers an intelligent data platform designed to facilitate digital transformation for enterprises globally. Founded in 2008 and headquartered in Redwood City, California, Delphix specializes in test data management software that supports a wide range of systems, including mainframes, Oracle databases, ERP applications, and Kubernetes containers. Its DataOps platform enables businesses to accelerate cloud migrations, custom development, and ERP rollouts by providing agile data management capabilities. By eliminating redundant infrastructure and streamlining processes, Delphix helps organizations in sectors such as financial services, telecommunications, consumer packaged goods, e-commerce, and manufacturing to effectively visualize and deliver data across major databases and data warehouses.

Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, dedicated to developing innovative treatments for multi-drug resistant (MDR) bacterial infections and rare diseases. Founded in 2013, the company is advancing several product candidates, including tebipenem pivoxil hydrobromide, an oral carbapenem-class antibiotic aimed at treating MDR gram-negative infections in adults. Additionally, Spero is developing SPR206, an intravenous agent for MDR gram-negative infections in hospital settings, and SPR720, an oral antibiotic targeting pulmonary non-tuberculous mycobacterial disease. The company collaborates with various partners, including Meiji Seika Pharma to support tebipenem HBr's development and the Bill & Melinda Gates Medical Research Institute for SPR720. Spero Therapeutics employs a focused approach to drug development, emphasizing novel mechanisms to address the urgent need for effective therapeutics against serious bacterial infections.

Silk Therapeutics develops, manufactures, and sells skincare products based on silk materials. It offers PureProC, a film formulation that surrounds, protects, stabilizes, and delivers the benefits of vitamin C for an extended duration with anti-aging and skin health benefits. The company sells its products through its online store. Silk Therapeutics skincare line features clean, highly effective anti-aging skincare and skin health products that are healthy enough to use on any skin type, including highly sensitive skin. The company's proprietary liquid silk technology platform was developed by company co-founders Greg Altman, Ph.D., and Rebecca Horan, Ph.D., foremost experts in the use of silk for health and wellness solutions—including effective stabilization and delivery of real silk molecules to the skin. Silk Therapeutics, Inc. was incorporated in 2013 and is based in Medford, Massachusetts.

We are inventors, marketers, consumers, photo buffs, friends, and co-workers. We are dedicated to helping you tell your family's stories. Whether it’s a picture from a day at the beach, or a video of the dog chasing a squirrel, there exists a special, unique story behind all of these images. But too often, due to our busy lives, these stories remain locked away on our digital devices, rarely finding the right way or the right time to be shared and enjoyed.

Scholar Rock, Inc. is a biotechnology company based in Cambridge, Massachusetts, specializing in the discovery and development of biologic therapies that selectively target dysregulated growth factors within disease microenvironments. The company's innovative approach focuses on modulating supracellular activation to address serious diseases, including fibrosis, musculoskeletal disorders, immuno-oncology, and autoimmune diseases. Scholar Rock's lead product candidate, SRK-015, is a first-in-class inhibitor designed to target the activation of the growth factor myostatin in skeletal muscle, specifically for the treatment of spinal muscular atrophy. The company is advancing this candidate through clinical development while also leveraging its proprietary platform to create a pipeline of additional product candidates aimed at transforming treatment for various serious conditions, including other neuromuscular disorders, cancer, and anemia.

Dune Medical Devices, established in 2002, specializes in innovative tissue characterization technologies aimed at improving cancer detection and treatment. The company's flagship product, the MarginProbe™ System, utilizes a proprietary radiofrequency spectroscopy platform to provide real-time detection of cancerous tissue during surgical procedures. This system allows surgeons to assess the margins of excised tissue, addressing the critical concern of whether all cancerous cells have been removed. Clinical research has demonstrated that the use of the MarginProbe™ System significantly reduces reoperation rates for breast cancer patients, thereby enhancing the effectiveness of surgical interventions. By enabling more accurate differentiation between cancerous and healthy tissue, Dune Medical Devices aims to improve patient outcomes and streamline the cancer care experience.

Sample6 is a biotechnology company that specializes in the development of a synthetic-biology based diagnostic system for bacteria. Its innovative technology enables enrichment-free detection of harmful bacteria, identifying levels as low as 1 CFU/ml within just four hours. The proprietary Bioillumination Platform, created by a team of researchers including Professor Tim Lu from MIT, allows for the engineering of bioparticles that target specific unwanted bacteria, illuminating them for detection. This system is coupled with sensitive sensor technology that provides rapid on-site results without the need for a laboratory. Sample6 aims to enhance public health and safety by enabling quick and efficient detection of harmful bacteria across various industries, including food production, retail, and healthcare, addressing environments where humans and bacteria interact.

SynapDx is a diagnostic company based in Lexington, Massachusetts, focused on providing laboratory testing services aimed at the early detection of autism spectrum disorders (ASDs) in children. Established by Stanley Lapidus, the company develops blood-based diagnostic tests that leverage insights from experts in ASD and gene expression. These tests are designed to assist healthcare providers in identifying early symptoms of autism, addressing the need for timely intervention in a condition that affects approximately 1 in 110 children in the United States. Through its innovative approach, SynapDx aims to enhance the diagnostic process for developmental disorders and improve outcomes for affected children and their families.

SynapDx is a diagnostic company based in Lexington, Massachusetts, focused on providing laboratory testing services aimed at the early detection of autism spectrum disorders (ASDs) in children. Established by Stanley Lapidus, the company develops blood-based diagnostic tests that leverage insights from experts in ASD and gene expression. These tests are designed to assist healthcare providers in identifying early symptoms of autism, addressing the need for timely intervention in a condition that affects approximately 1 in 110 children in the United States. Through its innovative approach, SynapDx aims to enhance the diagnostic process for developmental disorders and improve outcomes for affected children and their families.

New-Indy Containerboard is a manufacturer and supplier of recycled containerboard specifically for the corrugated box industry. Established in 2012 as a joint venture between the Kraft Group and Schwarz Partners, LP, both of which are family-owned companies with extensive backgrounds in paper and packaging, New-Indy has developed a significant presence in the market. The company operates three recycled brown paper mills and eight packaging facilities across the United States, focusing on sustainability and the efficient production of containerboard products.

Humedica is a clinical intelligence company that specializes in health analytics, offering tools designed for hospitals, physicians, and life sciences organizations. The company transforms unconnected data from various sources into actionable insights, enabling healthcare providers to make informed decisions. One of its key products, Humedica MinedShare, serves as a platform for clinical, operational, and financial benchmarking across the continuum of care, facilitating improved performance and outcomes in the healthcare sector. Through its innovative solutions, Humedica aims to enhance the quality of care and operational efficiency within the healthcare industry.

BlogTalkRadio, founded in 2006, is a site where anyone can set up a podcast or "radio talkshow" over the web. Users are given a phone number and can allow anyone to join (and optionally participate) in the call.

Patriot Place is a lifestyle center that offers dining, lodging, hospitality, shopping, entertainment and health care.

Acetylon Pharmaceuticals, Inc. is a biopharmaceutical company based in Boston, Massachusetts, focused on developing small molecule drugs that target epigenetic mechanisms to enhance therapeutic outcomes in cancer and other serious diseases. Founded in 2008, Acetylon specializes in creating selective inhibitors of histone deacetylase (HDAC), utilizing its proprietary drug discovery platform to develop a portfolio of optimized compounds for oral administration. The company's lead drug candidates, ACY-1215 and ACY-241, are selective HDAC6 inhibitors currently undergoing clinical trials for the treatment of multiple myeloma. Acetylon aims to leverage its expertise in epigenetic regulation to address critical unmet medical needs in oncology and beyond.

BlogTalkRadio, founded in 2006, is a site where anyone can set up a podcast or "radio talkshow" over the web. Users are given a phone number and can allow anyone to join (and optionally participate) in the call.

MatchMine is a media recommendation service that categorizes and analyzes your media likes and dislikes in order to serve you content that is more to your taste. Through its "MatchKey" technology, Matchmine uses demographic information about each user combined with a rating system to recommend media based upon your past media consumption. MatchMine will support three 3rd party sites at its launch which include Peerflix, FilmCrave and Fuzz.com. Like a [Last.FM](http://crunchbase.com/organization/Last.FM) for video, music, movies and blogs, MatchMine seeks to help you discover your new favorite media. Although their are no direct competitors, it will be interesting to see if CBS, which acquired Last.FM in May of 2007, uses Last.FM's recommendation engine for its own TV content. Additionally, [StumbleUpon](http://crunchbase.com/organization/stumbleupon) functions comparably by recommending media based on your previous ratings of similar media.

Httprint is a comprehensive service provider for the printing industry, offering enabling technology to streamline procurement and management processes for print buyers and sellers. With a background in outsourced print management, they provide customers with a team of experts to support or manage projects. Through their integrated website, buyers and suppliers can communicate and complete transactions online from anywhere in the world. Httprint's professional services team, comprised of print professionals, can assist buyers on all phases of the print transaction and are available for fully outsourced project management. Customers benefit from saving time and money by leveraging the expertise of httprint's team. Originally known as Landmark Productions, a brick and mortar print production company, httprint transitioned to the web in 2000, maintaining its reputation for serving companies lacking the resources or expertise for print services. Httprint serves as a centralized hub for purchasing activities, providing a total resource for buyers and suppliers in the print industry.